Sarcomatrix

Redefining Muscle Therapy with Science

Harnessing the power of cutting-edge research to develop transformative therapies for muscle-wasting diseases.

Science Behind Sarcomatrix

Our Scientific Innovations

Scientific breakthroughs transforming how we treat

muscle loss and degeneration.

Extracellular Matrix (ECM)

The ECM supports muscle development by guiding cell behavior, while α7β1 integrin connects myocytes to laminin for stability and growth.

Laminin

Laminin stabilizes muscle fibers, regulates growth, and maintains membrane integrity.

α7β1 Integrin

α7β1 integrin links muscle cells to the ECM, supporting growth, migration, and integrity by connecting to laminin.

S-969

S-969 enhances α7 integrin expression, aiding muscle regeneration in aging, chemotherapy, and muscular diseases.

Sunitinib

Sunitinib, an FDA-approved drug, enhances α7 integrin, promoting muscle repair by activating satellite cells.

LAM 111

LAM-111 is a potential therapy for LAMA2-RD, replacing defective laminin to support muscle function.

Putting It All Together

α7β1 integrin and laminin are key to muscle health, and their disruption leads to degeneration and weakness.